# Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia

> clinical trial · VERIFIED · 2026-07-30

Status: ACTIVE_NOT_RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Chronic Myeloid Leukemia, BCR-ABL1 Positive

- Company: National Cancer Institute (NCI)
- Sector: Chronic Myeloid Leukemia, BCR-ABL1 Positive
- Primary source: https://clinicaltrials.gov/study/NCT00070499

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.